Literature DB >> 22820238

Discrimination of type 2 diabetes mellitus corresponding to different traditional Chinese medicine syndromes based on plasma fatty acid profiles and chemometric methods.

Wenjuan Xu1, Liangxiao Zhang, Yuhong Huang, Qianxu Yang, Hongbin Xiao, Deqin Zhang.   

Abstract

AIMS OF THE STUDY: Traditional Chinese medicine (TCM) has a long history and particular advantages in the diagnosis and treatment of type 2 diabetes mellitus (T2DM). Syndrome differentiation is the foundation and essence of TCM theories. The aims of the study are to discriminate T2DM corresponding to different syndromes (Qi-deficiency, Qi and Yin-deficiency and Damp heat) and discover syndrome-related biomarkers using metabolomics technology.
MATERIALS AND METHODS: Plasma fatty acid profiles of 85 clinical samples were established by high performance liquid chromatography (HPLC). Moreover, some of the lipid parameters, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL), were obtained through clinical testing methods. Orthogonal signal correction-partial least squares (OSC-PLS) and uncorrelated linear discriminant analysis (ULDA) were employed to establish two-class models for three different syndromes.
RESULTS: Compared with the plasma fatty acid profiles of healthy controls, the characteristic fatty acids of three TCM syndromes were discovered (p<0.01). Totally, the plasma fatty acids of T2DM were up-regulated, while significant differences existed in different syndromes. Results of ULDA indicate that the three TCM syndromes could be effectively separated by the plasma fatty acid profiles and the syndrome-related biomarkers were also screened.
CONCLUSIONS: The fact that three TCM syndromes can be separated indicates certain metabolic differences in different TCM syndromes of T2DM really exist and such differences can be manifested by fatty acids and lipid parameters. The results benefit modern biological interpretation of the three TCM syndromes and in a sense the diagnosis and treatment of diabetes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820238     DOI: 10.1016/j.jep.2012.06.045

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study.

Authors:  Hao-Ying Dou; Yuan-Yuan Wang; Nan Yang; Ming-Li Heng; Xuan Zhou; Huai-En Bu; Fang Xu; Tie-Niu Zhao; He Huang; Hong-Wu Wang
Journal:  Chin J Integr Med       Date:  2016-02-26       Impact factor: 1.978

2.  A metabolomics approach to stratify patients diagnosed with diabetes mellitus into excess or deficiency syndromes.

Authors:  Tao Wu; Ming Yang; Tao Liu; Lili Yang; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-18       Impact factor: 2.629

3.  Clinical Applications of Omics Technologies on ZHENG Differentiation Research in Traditional Chinese Medicine.

Authors:  Ya-Nan Song; Gui-Biao Zhang; Yong-Yu Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

4.  Classification of Gan Dan Shi Re Pattern and Gan Shen Yin Xu Pattern in Patients with Hepatitis B Cirrhosis Using Metabonomics.

Authors:  Chao-Qun Zhao; Long Chen; Hong Cai; Wei-Li Yao; Qun Zhou; Hui-Ming Zhu; Yue Gao; Ping Liu; Xiao-Jun Gou; Hua Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-21       Impact factor: 2.629

5.  A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.

Authors:  Shui-Han Zhang; Yu-Hui Qin; Dan He; Jian-Hua Huang; Zhe-Yu Zhang; Qing Du; Wei-Jun Peng; Rong Yu; Si-Fang Zhang
Journal:  Drug Des Devel Ther       Date:  2019-11-28       Impact factor: 4.162

6.  Electroacupuncture at Acupoints Reverses Plasma Glutamate, Lipid, and LDL/VLDL in an Acute Migraine Rat Model: A (1) H NMR-Based Metabolomic Study.

Authors:  Zishan Gao; Xuguang Liu; Shuguang Yu; Qi Zhang; Qin Chen; Qiaofeng Wu; Juan Liu; Bo Sun; Li Fang; Jia Lin; Bing-Mei Zhu; Xianzhong Yan; Fanrong Liang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-28       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.